View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
July 18, 2022

Europe’s medical devices industry saw a rise of 12.50% in cross border deal activity during June 2022

By Carmen

Europe’s medical devices industry saw a rise of 12.50% in cross border deal activity during June 2022, when compared with the last 12-month average, led by ResMed’s $1bn acquisition of MediFox DAN Group, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.


A total of 27 medical devices industry cross border deals worth $2.1bn were announced for the region in June 2022, against the 12-month average of 24 deals.

Of all the deal types, M&A saw most activity in June 2022 with 13 transactions, representing a 48.2% share for the region.

In second place was venture financing with 11 deals, followed by private equity deals with three transactions, respectively capturing a 40.7% and 11.1% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $1.13bn, while private equity and venture financing deals totalled $837.86m and $169.15m, respectively.

Europe medical devices industry cross border deals in June 2022: Top deals

The top five medical devices cross border deals accounted for 94% of the overall value during June 2022.

The combined value of the top five medical devices cross border deals stood at $2.01bn, against the overall value of $2.1bn recorded for the month.

The top five medical devices industry cross border deals of June 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $797.86m private equity of SPT Labtech by EQT IX Fund

3) Azenta $85.5m acquisition deal with Barkey GmbHKG

4) The $80m venture financing of Proximie by Advent Life Sciences,British Patient Capital,Eight Roads Ventures,Emerson Collective,F Prime Capital,Global ventures,Maverick Ventures Israel,Minderoo Foundation,Mubadala Investment,Questa Capital Management and SoftBank Vision Fund 2

5) Fujirebio $42.15m acquisition deal with ADx NeuroSciences

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network